Indian units of global companies gain after GSK open offer
Reuters Market Eye - Shares in Indian units of global companies gain after GlaxoSmithKline Plc (GSK) (GSK.L) plans to raise its stake in its domestic unit GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS) via a $1 billion open offer.
Dealers say the open offer for GlaxoSmithKline Pharmaceuticals, which will be carried out at 26 percent above Friday's closing price, is raising hopes that other stake increases will also be carried out at similar premiums.
Among pharmaceutical units of global companies, Sanofi India Ltd (SANO.NS) gains 2.04 percent, Merck Ltd (MERK.NS) is up 5.62 percent, Abbott India Ltd (ABOT.NS) rises 2.49 percent, while Astrazeneca Pharma India Ltd (ASTR.NS) is 1.79 percent higher.
In other companies, Blue Dart Express Ltd (BLDT.NS) gains 1.11 percent, GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS) is up nearly 1 percent, while Nestle India Ltd (NEST.NS) rises 2.58 percent.
GlaxoSmithKline Pharmaceuticals shares surge 19 percent.
(Reporting by Abhishek Vishnoi)
- Tweet this
- Share this
- Digg this
Nitin Gadkari, former president of the Bharatiya Janata Party and a member of the BJP’s manifesto committee, speaks to Reuters. Here are the edited excerpts. Full Article
Turning smog into jewels - a Dutch designer's solution to Beijing's pollution. Video